Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Abbott initiates phase II trials with ABT-606

Oct. 7, 1998

Spotlight on antifungal agents for treating aspergillosis

Oct. 7, 1998

Gatifloxacin highlighted at ICAAC as an effective new treatment for pneumonia

Oct. 7, 1998

New broad-spectrum anti-MRSA pyrrolidinone cephalosporin and water-soluble prodrug from Roche

Oct. 6, 1998

Abbott obtains new ketolides with improved activity against MLS-resistant strains

Oct. 6, 1998

Lilly glycopeptide advances to phase II for various resistant infections

Oct. 6, 1998

Novel acid-stable macrolides from Abbott presented at ICAAC

Oct. 6, 1998

MiKasome phase I data presented at ICAAC; development update

Oct. 6, 1998

Preclinical profile of BI-397, a promising new glycopeptide antibiotic

Oct. 6, 1998

HMR-3647: the first ketolide to reach advanced-stage clinical testing

Oct. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...